Prognostic factors of differentiated thyroid cancer patients in Hospital Universiti Sains Malaysia

Singapore Medical Journal

Volumn 47, Issue 8, 2006, Pages 688-692

  Voralu, Kirtanaa ^a   Norsa'adah, B ^b   Naing, N N ^b   Biswal, B M ^c  

^a AIMST UNIVERSITY   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c Department of Oncology and Radiotherapy ^*

Author keywords

Cancer prognosis; Cancer survival rates; Differentiated thyroid cancer; Thyroid cancer

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGE; AGED; ANOREXIA; ARTICLE; ASPIRATION BIOPSY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MEDICAL RECORD; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THYROID CANCER; TUMOR VOLUME;

ADULT; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALAYSIA; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; THYROID NEOPLASMS;

EID: 33746869314     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Biersack HJ. Thyroid Cancer. Berlin: Springer, 2001.
2. Lim GCC, Yahaya H, Lim TO. The First Report of the National Cancer Registry Cancer Incidence in Malaysia. Kuala Lumpur: National Cancer Registry, 2002.
3. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997; 79:564-73.
4. World Health Organization. International Classification of Diseases for Oncology. 2nd ed. Geneva: WHO, 1992.
5. Hay ID, Grant CS, Bergstralh EJ, et al. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998; 124:958-64.
6. McConahey WM, Hay ID, Woolner LB, Van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 1986; 61:978-96.
7. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10-year follow-up report of the impact of therapy in 576 patients. Am J Med 1981; 70:511-8.
8. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systemic autopsy study. Cancer 1985; 56:531-8.
9. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognosis factors in patients with differentiated thyroid cancer. Cancer 1985; 55:794-804.
10. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71:414-24.
11. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgery and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97:418-28.
12. Erratum in: Am J Med 1995; 98:215.
13. Comment in: Am J Med 1994; 97:499-500.
14. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75:714-20.
15. Dineen SF, Valimaki MJ, Bergsath EJ, et al. Distant metastases in papillary thyroid carcinoma: 100 cases observed ay one instituition during 5 decades. J Clin Endocrinol Metab 1995; 80:2041-45.
16. Farahati J, Reiners C, Stuschke M, et al. Differentiated thyroid cancer: Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration. Cancer 1996; 77 172-80.